Financial Associated Press, December 16 - Hong Kong biomedical stocks rebounded, with Wuxi apptec up more than 8% and Yaoming biology up more than 5%.
Financial Associated Press, December 16 - Hong Kong biomedical stocks rebounded, with Wuxi apptec up more than 8% and Yaoming biology up more than 5%.
This text is a result of machine translation.
Related companies：
Briefing Yesterday 05:05 PM
Dongfang Electric: pre bid winning of 210 million yuan reduction furnace procurement project
In-depth
Apr 26, 2022 12:26 PM
Apr 25, 2022 01:02 PM
Apr 21, 2022 07:07 PM
Research
Consumer StaplesChina’s Food and Beverage Industry in Search of Methods to Shrink its Carbon Footprints
Apr 19, 2022 11:38 PM
Briefing Mar 13, 2022 08:49 PM
· Financials
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
Briefing Mar 09, 2022 05:49 PM
Tianci materials: the net profit in the first two months increased by about 470% year-on-year
Consumer Discretionary
Trip.com Q1 2021 Financial Results: Net Profit Increased by 80%
On May 19, China's travel service provider, Trip.com filed unaudited financial results for the first quarter ending March 31, 2021, which is the company's first financial report after the secondary listing on the Hong Kong Stock Exchange.
May 19, 2021 12:44 PM
Consumer Staples · Analysis
Trip.com's New Start – the Hong Kong IPO
Since the Hong Kong exchange relaxed its rules and uncertainties began to grow in the Sino-American relationship, a number of China concept stocks have chosen to both remain in the US and launch a second listing in Hong Kong. Trip.com recently became one of them.
Apr 28, 2021 11:39 AM
Briefing Feb 15, 2022 12:19 PM
· Financials
For half a day, the main funds increased their positions in the power equipment sector and sold off bank stocks
See more
Read next
In-depth
In-depth
Technology
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
May 21, 2022 12:51 PM
In-depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.